CLINICAL_TRIALS
trial_result
· 2020-11-27
Clinical Trial Update: Effects of Fuzheng Huayu Tablets on COVID-19 [Phase 4]
Summary
Phase 4 trial evaluating Fuzheng Huayu Tablets for Novel Coronavirus Pneumonia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ShuGuang Hospital | Conditions: Novel Coronavirus Pneumonia | Phase 4 | Status: COMPLETED